J&J ordered to pay $4.68 billion to talc-powder plaintiffs

04:35 EDT 13 Jul 2018 | Pharmafile

A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women who claimed that the multinational’s talc-based products had caused them to develop ovarian cancer.

The jury awarded plaintiffs $550 million in compensatory damages and $4.14 billion in punitive damages in a record pay-out that has been described by a J&J spokesperson as “fundamentally unfair”.  The massive pay-out followed a six week trial in which testimony was heard from nearly a dozen experts on both sides.

read more

Original Article: J&J ordered to pay $4.68 billion to talc-powder plaintiffs


More From BioPortfolio on "J&J ordered to pay $4.68 billion to talc-powder plaintiffs"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...